Drug-Induced Liver Disease - Describe Your Experience. The symptoms of drug-induced liver disease can vary greatly from patient to patient. What were your symptoms at. Stress management diet. There are many things that can add to the stress of daily life -- and plenty of things you can do to help avoid stress. Many people don’t. Sites by Individuals. The Paleo Diet Defined is my concise definition of the core paleo diet and the many variations of it. Life Expectancy in the Paleolithic by Ron. A subjective unpleasant, wavelike sensation in the back of the throat, epigastrium, or abdomen that may lead to the urge or need to vomit. Oxalateby Jack Norris, RD . This article does not address that subject – info can be found in the article Calcium and Vitamin D. Oxalate is also known for the part it plays in calcium- oxalate kidney stones, which is the most common form of kidney stone. In many cases, getting a kidney stone is a one time thing and does not occur again. Increasing fluid intake can cut the incidence of getting another stone in half. Cutting down on the amount of oxalate in the diet is another strategy for reducing stone recurrence. Some calcium- oxalate stone formers are prescribed potassium- citrate tablets which are also effective at reducing stones. Oxalate is generally not found in animal products while many plant foods are moderate or high, and some are extremely high (such as spinach, beets, beet greens, sweet potatoes, peanuts, rhubarb, and swiss chard). ![]() Despite this, a study from the Harvard School of Public Health found that people following a plant- based eating pattern had a lower occurrence of kidney stones (5. There is no research on kidney stone frequency in vegans, though anecdotally I know of some who have gotten stones. Of course, I also know of meat- eaters who have gotten kidney stones. But is the average vegan at a higher or lower risk? Vegan diets are higher in some elements that increase the risk of stones, lower in some, and higher in some things that prevent stones, so it is hard to say. The story regarding oxalate does not end with kidney stones. ![]() There is currently an entire community built around the idea that absorbing too much oxalate, known as enteric hyperoxaluria, either causes or exacerbates many diseases such as fibromyalgia, interstitial cystitis, vulvodynia, depression, arthritis, autism, and a variety of digestive disorders (which, in turn, exacerbate hyperoxaluria by allowing even more oxalate to be absorbed). According to Low. Oxalate. info, leaky gut syndrome, in which molecules are absorbed from the digestive tract at a higher than normal rate, can cause hyperoxaluria. They also say that you cannot rely on getting a kidney stone as a warning sign before oxalate accumulates in other tissues. There is not much research (on humans) regarding hyperoxaluria and diseases other than kidney stones and vulvodynia, so it is hard to say much about them with any certainty. However, many people have reported improved health on a low- oxalate diet and given the high amount of oxalate in some plant foods, it might be a good idea for vegans to be aware of this issue and not eat unusually high amounts of these foods. Here are some other tips for minimizing problems from oxalate: Boil high- oxalate leafy greens and discard the water. Meet the RDA for calcium. Eat high- calcium foods or take calcium with meals; calcium citrate if you have a history of calcium- oxalate stones. Drink plenty of fluid. Do not include large amounts of high- oxalate vegetables in your green smoothies. Do not take large amounts of vitamin C. If you have a history of calcium- oxalate kidney stones or suspect you have hyperoxaluria, there are a few more things you can do such as limit oxalate as much as possible, add citrate to your diet (through orange or lemon juice, or calcium citrate), minimize added fructose and sodium, or try a probiotic supplement as described below. Please see the Contents above for quick links to more details about all of these topics as well as tables of the oxalate content of foods and other helpful resources. Background. Oxalate is a small molecule found in large amounts in many plants foods but not found in animal foods. Our bodies make oxalate as an end product of metabolism (primarily the metabolism of the protein amino acids glycine and serine, but also of vitamin C and possibly fructose).
However, our bodies do not use oxalate in any way, nor degrade it, and it must be excreted through the urine or feces. Even if oxalate intake is zero, oxalate will be excreted in the urine as a result of normal metabolism. Oxalate is made of two carbons and four oxygen with a charge of - 2, making it attracted to other molecules with a charge of +2; especially calcium and to a lesser extent magnesium. When oxalate combines with calcium in urine, it becomes insoluble (i. If enough calcium- oxalate crystals form in the bladder, kidney stones can develop. In the USA's National Health And Nutrition Examination Survey (NHANES) 2. Approximately 2. 5% of untreated patients experience a new episode within 5 years (6. Calcium- oxalate are the most common form of kidney stones, accounting for about 7. It is essential to determine the type of stone (calcium- oxalate, calcium- phosphate, uric acid, cystine, or struvite) as treatment methods can conflict. An increased level of oxalate in the urine is a risk for calcium- oxalate kidney stones. For adults this is considered to be above 4. When someone with a kidney stone is tested for various metabolic defects that can cause kidney stones (such as kidney problems that cause acidosis) and none are found, their kidney stone is labelled . None of the participants had a history of digestive disorders (which can increase oxalate absorption). They found a small, but statistically significant difference in oxalate absorption between stone formers (8. There were no gender or age differences. Absorption values greater than 2. When extrapolated to higher oxalate diets, the researchers believed that . Samples of the food were analyzed for oxalate content; in other words, the amounts were not simply based on food tables (9). Patients with idiopathic kidney stones tend to have high rates of osteopenia and osteoporosis. One study showed that 5. In another study, 5. Hyperoxaluria. Hyperoxaluria is a condition in which the amount of oxalate in the urine becomes very high, so high that it can cause severe kidney damage. Oxalosis refers to oxalate deposits in the kidney. There are two types of hyperoxaluria, primary and enteric. Primary hyperoxaluria is a genetic disease in which the liver produces too much oxalate. It occurs in 1 out of 1. Enteric hyperoxaluria is when too much oxalate is absorbed from the digestive tract. This typically happens in cases of intestinal diseases and more rarely in cases of very high- oxalate diets. In cases of hyperoxaluria, it is possible that the build- up of oxalate in the body can become so great that it doesn't just damage the kidneys, but can be deposited in other parts of the body. This has led to much speculation that people suffering from diseases other than kidney stones are actually suffering from an accumulation of oxalate in other tissues. If you suspect that you are suffering from hyperoxaluria, you should talk to a health professional. The Mayo Clinic has some helpful information in their article Hyperoxaluria and oxalosis as does the Oxalosis and Hyperoxaluria Foundation (OHF). Because kidney stones are rare in childhood, the OHF recommends that all children and adolescents who have symptoms of kidney stones be screened for hyperoxaluria (more info). Very high- oxalate foods should still be avoided. Low. Oxalate. info is a popular website that provides support for people suffering from hyperoxaluria. They suggest that hyperoxaluria may play a significant role in autism, COPD/asthma, and thyroid disease. They say that, . Vulvodynia is when the vulva becomes very painful upon touch or pressure. Hyperoxaluria could lead to oxalate crystals forming in these sensitive tissues causing the pain. There is a 1. 99. Journal of Reproductive Medicine, in which a woman who had suffered from vulvodynia for four years was given calcium citrate to reduce the oxalate levels in her body. After a year, she was pain- free. Upon discontinuing the calcium citrate, her symptoms returned only to disappear again after reintroduction of the calcium citrate (2). A 1. 99. 7 study from Good Samaritan Hospital in Cincinnati showed some mixed results on oxalate and vulvodynia (3). They were not able to predict vulvar pain by measuring oxalate excretion. However, a small number of women (5 out of 5. A 1. 99. 9 case- control study from the University of Michigan found that women with vulvar vestibulitis syndrome (VVS), a form of vulvodynia, consumed more high and medium rather than low oxalate foods, but there was no significant difference in average oxalate intake based on a questionnaire regarding the previous 4- weeks (7. Bacterial vaginosis, yeast infections, and human papillomavirus were strongly associated with VVS. A 2. 00. 8 study from the University of Minnesota found no association between oxalate intake in vulvodynia cases vs. Trials are being conducted to see if a low- oxalate diet will improve symptoms (7). Oxalate deposits are common in the human thyroid (8), but there was no more research than that. Digestive disorders – Hyperoxaluria is common in Crohn's disease (see below), but is not considered to be a cause. I could not find any research on irritable bowel syndrome and very little on ulcerative colitis. I found no research on asthma, arthritis, fibromyalgia, interstitial cystitis, or depression. Digestive Disorders. Fat malabsorption results in unabsorbed fat forming insoluble soaps with calcium. This prevents calcium from being available to combine with oxalate in the gut, resulting in a higher oxalate absorption (5. Short bowel syndrome, in which part of the bowel is surgically removed, is a common reason for fat malabsorption. Short bowel syndrome is common in people with Crohn's disease and in bariatric surgery. People with cystic fibrosis are also at an increased risk of kidney stones (5, 6), likely due to pancreatic insufficiency leading to fat malabsorption and/or antibiotic therapy. Patients with Crohn's are more likely to have hyperoxaluria, and this hyperoxaluria is more common in Crohn's patients who have had a bowel resection (part of their digestive tract removed). Such patients are at a higher risk of calcium- oxalate kidney stones and in some cases oxalosis results and can cause kidney failure. Approach Considerations, Treatment of Asymptomatic Gallstones, Treatment of Patients with Symptomatic Gallstones. Douglas M Heuman, MD, FACP, FACG, AGAF Chief of Hepatology, Hunter Holmes Mc. Guire Department of Veterans Affairs Medical Center; Professor, Department of Internal Medicine, Division of Gastroenterology, Virginia Commonwealth University School of Medicine. Douglas M Heuman, MD, FACP, FACG, AGAF is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Physicians, American Gastroenterological Association. Disclosure: Received grant/research funds from Novartis for other; Received grant/research funds from Bayer for other; Received grant/research funds from Otsuka for none; Received grant/research funds from Bristol Myers Squibb for other; Received none from Scynexis for none; Received grant/research funds from Salix for other; Received grant/research funds from Mann. Kind for other. BS Anand, MD Professor, Department of Internal Medicine, Division of Gastroenterology, Baylor College of Medicine. BS Anand, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy. Disclosure: Nothing to disclose. David Eric Bernstein, MD Director of Hepatology, North Shore University Hospital; Professor of Clinical Medicine, Albert Einstein College of Medicine. David Eric Bernstein, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy. Disclosure: Nothing to disclose. Barry E Brenner, MD, Ph. D, FACEP Professor of Emergency Medicine, Professor of Internal Medicine, Program Director, Emergency Medicine, Case Medical Center, University Hospitals, Case Western Reserve University School of Medicine. Barry E Brenner, MD, Ph. D, FACEP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Chest Physicians, American College of Emergency Physicians, American College of Physicians, American Heart Association, American Thoracic Society, Arkansas Medical Society, New York Academy of Medicine, New York Academy of Sciences, and Society for Academic Emergency Medicine. Disclosure: Nothing to disclose. David FM Brown, MD Associate Professor, Division of Emergency Medicine, Harvard Medical School; Vice Chair, Department of Emergency Medicine, Massachusetts General Hospital. David FM Brown, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine. Disclosure: Nothing to disclose. William K Chiang, MD Associate Professor, Department of Emergency Medicine, New York University School of Medicine; Chief of Service, Department of Emergency Medicine, Bellevue Hospital Center. William K Chiang, MD is a member of the following medical societies: American Academy of Clinical Toxicology, American College of Medical Toxicology, and Society for Academic Emergency Medicine. Disclosure: Nothing to disclose. Alfred Cuschieri, MD, Ch. M, FRSE, FRCS, Head, Professor, Department of Surgery and Molecular Oncology, University of Dundee, UK Disclosure: Nothing to disclose. Imad S Dandan, MD Consulting Surgeon, Department of Surgery, Trauma Section, Scripps Memorial Hospital. Imad S Dandan, MD is a member of the following medical societies: American Association for the Surgery of Trauma, American College of Surgeons, American Medical Association, American Trauma Society, California Medical Association, and Society of Critical Care Medicine. Disclosure: Nothing to disclose. David Greenwald, MD Associate Professor of Clinical Medicine, Fellowship Program Director, Department of Medicine, Division of Gastroenterology, Montefiore Medical Center, Albert Einstein College of Medicine. David Greenwald, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy, and New York Society for Gastrointestinal Endoscopy. Disclosure: Nothing to disclose. Eugene Hardin, MD, FAAEM, FACEP Former Chair and Associate Professor, Department of Emergency Medicine, Charles Drew University of Medicine and Science; Former Chair, Department of Emergency Medicine, Martin Luther King Jr/Drew Medical Center Disclosure: Nothing to disclose. Faye Maryann Lee, MD Staff Physician, Department of Emergency Medicine, New York University/Bellevue Hospital Center. Faye Maryann Lee, MD is a member of the following medical societies: Phi Beta Kappa. Disclosure: Nothing to disclose. Sally Santen, MD Program Director, Assistant Professor, Department of Emergency Medicine, Vanderbilt University. Sally Santen, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine. Disclosure: Nothing to disclose. Assaad M Soweid, MD, FASGE, FACG Associate Professor of Clinical Medicine, Endosonography and Advanced Therapeutic Endoscopy, Director, Endoscopy- Bronchoscopy Unit, Division of Gastroenterology, Department of Internal Medicine, American University of Beirut Medical Center, Lebanon. Assaad M Soweid, MD, FASGE, FACG is a member of the following medical societies: American College of Gastroenterology, American College of Physicians, American College of Physicians- American Society of Internal Medicine, American Gynecological and Obstetrical Society, and American Medical Association. Disclosure: Nothing to disclose. Francisco Talavera, Pharm. D, Ph. D Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor- in- Chief, Medscape Drug Reference. Disclosure: Medscape Salary Employment.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
June 2017
Categories |